Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
06/14/20186:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/14/20186:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/14/20186:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
06/05/20185:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/31/201811:18AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/31/201811:16AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/29/20186:53AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/24/20187:00AMPR Newswire (US)AcelRx announces FDA acceptance of NDA for DSUVIANASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/24/20186:06AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/23/20186:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/23/20187:00AMPR Newswire (US)Three Arch's shares of AcelRx common stock acquired in a private transaction led by Leerink Revelation Partners and Industry ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/22/201811:45AMPR Newswire (US)AcelRx Pharmaceuticals to Present at Jefferies 2018 Global Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/10/20186:12AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/09/20184:05PMPR Newswire (US)AcelRx Pharmaceuticals Reports First Quarter 2018 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
05/09/20187:00AMPR Newswire (US)AcelRx resubmits New Drug Application for DSUVIA™NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/30/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals Reports Publication Analyzing Errors Associated with Existing IV Patient-Controlled Analgesia SystemsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/25/20184:30PMPR Newswire (US)AcelRx to announce first quarter 2018 results and provide a corporate update on Wednesday, May 9th, 2018NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/23/20185:11PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/23/20185:10PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/18/20185:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/18/20185:06PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/18/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals Announces Publication Concluding that Sublingual Sufentanil Tablets Provide the Opportunity to Non-Inv...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/16/20187:00AMPR Newswire (US)AcelRx Announces Completion of the Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 2018NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/12/20184:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
04/11/20189:15AMPR Newswire (US)AcelRx Announces Publication Analyzing the Cost of Administering IV Morphine for Acute Pain in Emergency Departments in Europ...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/27/20187:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/27/20187:00AMPR Newswire (US)AcelRx announces appointment of John Saia as General CounselNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/09/20186:09AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/09/20186:09AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/08/20184:06PMPR Newswire (US)AcelRx Pharmaceuticals Reports Fourth Quarter 2017 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX